8-K: Arcadia Biosciences Q2: Revenue Up, Net Loss Widens

Arcadia Biosciences reported an 11% increase in second-quarter revenues driven by Zola coconut water sales, but net loss widened significantly due to a $4.5 million credit loss on a note receivable.

Summary

• Total revenues for the second quarter of 2025 increased 11% year-over-year to $1.455 million.
• Zola coconut water revenues grew 24% in the second quarter of 2025 and 47% in the first half of 2025, surpassing the performance of the category.
• Gross margins have consistently exceeded 30% for ten straight quarters.
• Net loss attributable to common stockholders for the second quarter of 2025 was $4.458 million, or $3.26 per share, compared to net income of $1.061 million, or $0.78 per share, in the second quarter of 2024.
• Net loss for the first half of 2025 was $1.859 million, or $1.36 per share, compared to a net loss of $1.362 million, or $1.00 per share, in the first half of 2024.
• A $4.5 million credit loss was recognized on a note receivable from Above Food Corp. due to non-payment of the first principal and accrued interest payment.
• Received 2.7 million shares of Above Food Ingredients Inc. (ABVE) stock as partial repayment of a $6 million note receivable, with approximately 800,000 shares remaining issuable.
• Eliminated $1 million in contingent liabilities in the second quarter of 2025, bringing the year-to-date total to $2 million, by completing the exit from legacy businesses.
• The pending business combination with Roosevelt Resources is moving forward, with an amended Form S-4 registration statement filed with the SEC.

Sentiment

Score: 4

Explanation: While revenue growth in the core Zola business is positive and gross margins are strong, the significant net loss driven by a large credit loss and declining cash position are major concerns. The ongoing merger provides future potential but also introduces uncertainty and transaction costs. The non-payment from Above Food is a clear negative financial event.

Positives

• Total revenues increased 11% year-over-year in the second quarter of 2025 to $1.455 million.
• Zola coconut water revenues grew 24% in the second quarter of 2025 and 47% in the first half of 2025, surpassing category performance.
• Gross margins have consistently exceeded 30% for ten consecutive quarters.
• Eliminated $1 million in contingent liabilities in the second quarter of 2025, contributing to a total of $2 million in liabilities eliminated year-to-date from exiting legacy businesses.
• Received 2.7 million shares of Above Food Ingredients Inc. (ABVE) stock as partial repayment of a $6 million note receivable.
• Underlying operating expenses remain low despite almost $700,000 in transaction fees this quarter.

Negatives

• Net loss attributable to common stockholders for the second quarter of 2025 was $4.458 million, a significant reduction from $1.061 million net income in the second quarter of 2024.
• Net loss per share for the second quarter of 2025 was $3.26, compared to $0.78 net income per share in the second quarter of 2024.
• Recognized a $4.5 million credit loss related to the note receivable from Above Food Corp. due to non-payment of the first principal and accrued interest payment.
• Approximately 800,000 shares relating to the Above Food stock election notice remain issuable.
• Total operating expenses increased significantly in the second quarter of 2025 by $2.630 million (390%) compared to the second quarter of 2024, primarily due to the absence of a $4.0 million gain on the sale of patents that occurred in the prior year.
• Cash and cash equivalents decreased from $4.242 million at December 31, 2024, to $1.376 million at June 30, 2025.

Risks

• Ability to obtain sufficient funding required to continue operations and planned activities.
• Ability to obtain stockholder approvals required to complete the proposed business combination transaction with Roosevelt Resources.
• Satisfaction of closing conditions contained in the agreements relating to the Roosevelt Resources transaction.
• Occurrence of any event, change, or other circumstance or condition that could give rise to the termination of the proposed business combination transaction.
• Uncertainty regarding the repayment of the remaining outstanding balance of the note receivable from Above Food Corp.
• Potential for further credit losses if the remaining Above Food shares are not issued or if the remaining balance is not paid.

Future Outlook

The company is actively pursuing the completion of its business combination with Roosevelt Resources, which involves a definitive proxy statement/prospectus to be mailed to stockholders after the Registration Statement on Form S-4 is declared effective by the SEC. The company continues to pursue repayment of the remaining outstanding balance of the note receivable from Above Food Corp. and the issuance of approximately 800,000 remaining shares.

Management Comments

• "We are very pleased with our performance for the second quarter of 2025." T.J. Schaefer, CEO.
• "While our total revenues have increased 11% compared to the second quarter of 2024, Zola coconut water revenues have grown 24% and once again surpassed the performance of the category." T.J. Schaefer, CEO.
• "Our gross margins have now exceeded 30% for ten straight quarters, while our underlying operating expenses remain low, even with almost $700,000 in transaction fees this quarter." T.J. Schaefer, CEO.
• "In addition to our strong operating performance, we received 2.7 million shares of stock in Above Food Ingredients Inc. as a partial repayment of the $6 million principal amount of the note receivable related to the sale of GoodWheatTM assets in the second quarter of 2024, and we continue to pursue repayment of the remaining outstanding balance." T.J. Schaefer, CEO.
• "We have also completed the exit from our legacy businesses following the agreement with Bioseed Research India, which resulted in the elimination of the remaining $1 million in contingent liabilities, bringing the total to $2 million of liabilities that have been eliminated year-to-date." T.J. Schaefer, CEO.
• "Our pending business combination with Roosevelt Resources continues to move forward." T.J. Schaefer, CEO.
• "We recently filed an amendment to the initial Form S-4 registration statement to provide responses to comments received from the SEC and to provide updated financial information through the first quarter of 2025 for both Arcadia Biosciences and Roosevelt Resources." T.J. Schaefer, CEO.

Industry Context

The company operates in the innovative wellness products sector, specifically with Zola coconut water. The reported growth in Zola revenues surpassing category performance suggests a strong product within the competitive beverage market. The ongoing business combination with Roosevelt Resources indicates a strategic shift or expansion, potentially into new markets or a consolidation play within the broader wellness or agricultural technology space, given Arcadia's roots in agricultural innovation. The exit from legacy businesses and patent sales suggest a focus on core profitable segments and streamlining operations, aligning with broader industry trends of portfolio optimization.

Comparison to Industry Standards

• Zola coconut water's 24% Q2 2025 revenue growth and 47% H1 2025 growth, surpassing category performance, indicates strong market penetration and consumer acceptance compared to general trends in the competitive beverage market.
• Maintaining gross margins above 30% for ten consecutive quarters suggests efficient cost management relative to industry peers, especially in the consumer packaged goods sector where margins can be pressured.
• The significant net loss, primarily driven by a $4.5 million credit loss on a note receivable, highlights a specific financial risk event that is not typical of ongoing operational performance comparisons but rather a one-time impairment.
• The strategic shift towards the Roosevelt Resources merger and divestment of legacy assets (like GoodWheat and RS durum wheat patents) aligns with broader industry trends of companies streamlining portfolios and seeking synergistic combinations to enhance shareholder value or enter new growth areas.

Stakeholder Impact

• Shareholders: Potential dilution from the all-stock merger with Roosevelt Resources; significant net loss and credit loss impact earnings per share; ongoing uncertainty regarding the merger and the Above Food receivable.
• Employees: No direct impact mentioned, but strategic shifts and mergers can lead to organizational changes.
• Customers: Zola coconut water customers benefit from continued product availability and growth.
• Creditors: The $4.5 million credit loss on the Above Food note highlights counterparty risk; overall financial health impacts creditworthiness.

Next Steps

• SEC to declare the Registration Statement on Form S-4 effective.
• Mail a definitive proxy statement/prospectus to Arcadia stockholders.
• Hold a meeting of stockholders to consider matters relating to the proposed transaction with Roosevelt Resources.
• Continue to pursue repayment of the remaining outstanding balance of the note receivable from Above Food Corp.
• Seek issuance of approximately 800,000 remaining shares from Above Food Ingredients Inc.

Key Dates

Recommendation

While the core Zola business shows strong revenue growth and healthy gross margins, the significant net loss driven by a substantial credit loss from Above Food Corp. and the declining cash balance introduce considerable financial uncertainty. The pending all-stock merger with Roosevelt Resources presents a potential strategic pivot, but its completion and integration risks are still present. Given the mixed financial performance and the ongoing strategic transaction, a 'hold' recommendation is appropriate for investors to monitor the resolution of the Above Food receivable and the progress of the Roosevelt merger before making further investment decisions.

Keywords

Arcadia Biosciences, RKDA, Financial Results, Second Quarter 2025, Zola Coconut Water, Above Food, Roosevelt Resources, SEC Filing, 8-K, Net Loss, Revenue Growth, Credit Loss, Business Combination, Consumer Wellness, Specialty Ingredients